Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing

Details for Australian Patent Application No. 2008225100 (hide)

Owner Sarentis Therapeutics, Inc. SloanKettering Institute for Cancer Research Mayo Foundation for Medical Education and Research

Inventors Richelson, Elliott; Pasternak, Gavril W.; Barbut, Denise

Agent Spruson & Ferguson

Pub. Number AU-A-2008225100

PCT Pub. Number WO2008/112807

Priority 61/014,316 17.12.07 US; 60/950,772 19.07.07 US; 60/906,618 12.03.07 US; 60/930,243 14.05.07 US

Filing date 12 March 2008

Wipo publication date 18 September 2008

International Classifications

A01N 37/18 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/112807 Priority application(s): WO2008/112807

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008225124-High selectivity polymer-nano-porous particle membrane structures

2008225096-Hybrid pilot configuration